Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT02100722Not ApplicableCompleted

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

Role: collaborator

NCT03731455Not ApplicableCompleted

WISE Cortical Strip for Intraoperative Neurophysiological Monitoring

Role: collaborator

NCT03892824Not ApplicableActive Not Recruiting

Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants

Role: collaborator

NCT04024956Not ApplicableCompleted

Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage in Hepatobiliary and Pancreatic Surgery

Role: collaborator

NCT03871231Not ApplicableTerminated

Unpinning Termination Therapy for VT/VF

Role: collaborator

NCT02869087Not ApplicableCompleted

The DESappear Study: Drug Eluting Scaffold

Role: collaborator

NCT03225612Not ApplicableUnknown

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Role: collaborator

NCT01405287Phase 2Completed

Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

Role: collaborator

All 8 trials loaded